Kornitzer Capital Management Inc Gilead Sciences, Inc. Transaction History

Kornitzer Capital Management Inc

$5.21 Billion
Q3 2024

A detailed history of Kornitzer Capital Management Inc transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Kornitzer Capital Management Inc holds 370,853 shares of GILD stock, worth $33.9 Million. This represents 0.6% of its overall portfolio holdings.

Number of Shares

370,853

Previous 370,878 0.01%

Holding current value

$33.9 Million

Previous $25.4 Million 22.16%

% of portfolio

0.6%

Previous 0.5%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	SELL	$66.59 - $83.99 $1,664 - $2,099	-25 Reduced 0.01%	370,853 $31.1 Million
Q2 2024 Aug 02, 2024	SELL	$63.15 - $72.88 $252,915 - $291,884	-4,005 Reduced 1.07%	370,878 $25.4 Million
Q1 2024 May 01, 2024	SELL	$71.58 - $87.29 $31,638 - $38,582	-442 Reduced 0.12%	374,883 $27.5 Million
Q4 2023 Jan 31, 2024	SELL	$73.27 - $83.09 $85,725 - $97,215	-1,170 Reduced 0.31%	375,325 $30.4 Million
Q3 2023 Oct 31, 2023	SELL	$73.94 - $80.67 $54,937 - $59,937	-743 Reduced 0.2%	376,495 $28.2 Million
Q2 2023 Aug 01, 2023	SELL	$76.01 - $86.7 $38,005 - $43,350	-500 Reduced 0.13%	377,238 $29.1 Million
Q1 2023 May 09, 2023	SELL	$77.31 - $88.08 $109,239 - $124,457	-1,413 Reduced 0.37%	377,738 $31.3 Million
Q4 2022 Feb 02, 2023	SELL	$62.32 - $89.47 $143,647 - $206,228	-2,305 Reduced 0.6%	379,151 $32.6 Million
Q3 2022 Nov 03, 2022	BUY	$59.54 - $68.01 $112,709 - $128,742	1,893 Added 0.5%	381,456 $23.5 Million
Q2 2022 Aug 03, 2022	BUY	$57.72 - $65.01 $1.78 Million - $2.01 Million	30,915 Added 8.87%	379,563 $23.5 Million
Q1 2022 Apr 27, 2022	BUY	$57.92 - $72.58 $181,057 - $226,885	3,126 Added 0.9%	348,648 $20.7 Million
Q4 2021 Feb 01, 2022	SELL	$64.88 - $73.64 $219,943 - $249,639	-3,390 Reduced 0.97%	345,522 $25.1 Million
Q3 2021 Nov 03, 2021	BUY	$67.69 - $73.03 $80,686 - $87,051	1,192 Added 0.34%	348,912 $24.4 Million
Q2 2021 Jul 30, 2021	BUY	$63.47 - $69.35 $978,072 - $1.07 Million	15,410 Added 4.64%	347,720 $23.9 Million
Q1 2021 Apr 30, 2021	BUY	$60.0 - $68.46 $2.14 Million - $2.44 Million	35,645 Added 12.02%	332,310 $21.5 Million
Q4 2020 Jan 29, 2021	BUY	$56.65 - $64.55 $1.79 Million - $2.04 Million	31,592 Added 11.92%	296,665 $17.3 Million
Q3 2020 Oct 30, 2020	BUY	$62.1 - $78.08 $1.72 Million - $2.16 Million	27,675 Added 11.66%	265,073 $16.8 Million
Q2 2020 Aug 03, 2020	BUY	$72.34 - $84.0 $2.91 Million - $3.38 Million	40,213 Added 20.39%	237,398 $18.3 Million
Q1 2020 Apr 30, 2020	BUY	$62.63 - $80.22 $267,430 - $342,539	4,270 Added 2.21%	197,185 $14.7 Million
Q4 2019 Jan 31, 2020	BUY	$61.62 - $67.78 $59,463 - $65,407	965 Added 0.5%	192,915 $12.5 Million
Q3 2019 Nov 04, 2019	BUY	$62.51 - $69.0 $361,307 - $398,820	5,780 Added 3.1%	191,950 $12.2 Million
Q2 2019 Jul 31, 2019	SELL	$61.87 - $69.38 $149,725 - $167,899	-2,420 Reduced 1.28%	186,170 $12.6 Million
Q1 2019 May 01, 2019	BUY	$62.53 - $70.05 $885,737 - $992,258	14,165 Added 8.12%	188,590 $12.3 Million
Q4 2018 Jan 31, 2019	BUY	$60.54 - $79.0 $16,043 - $20,935	265 Added 0.15%	174,425 $10.9 Million
Q3 2018 Nov 13, 2018	BUY	$71.28 - $78.92 $11,404 - $12,627	160 Added 0.09%	174,160 $13.4 Million
Q2 2018 Aug 02, 2018	BUY	$64.88 - $75.68 $46,064 - $53,732	710 Added 0.41%	174,000 $12.3 Million
Q1 2018 Apr 30, 2018	SELL	$72.84 - $88.8 $98,698 - $120,324	-1,355 Reduced 0.78%	173,290 $13.1 Million
Q4 2017 Jan 31, 2018	SELL	$71.15 - $83.52 $4.05 Million - $4.76 Million	-56,979 Reduced 24.6%	174,645 $12.5 Million
Q3 2017 Oct 31, 2017	BUY	$72.11 - $85.47 $16.7 Million - $19.8 Million	231,624	231,624 $18.8 Million

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $114B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kornitzer Capital Management Inc , based on Form 13F filings with the SEC.

News

Stay updated on Kornitzer Capital Management Inc with notifications on news.

Account

Kornitzer Capital Management Inc Gilead Sciences, Inc. Transaction History